Adipocytokines: Leptin - The classical, resistin - The controversical, adiponectin - The promising, and more to come

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 19, Issue 4, 2005, Pages 525-546

  Koerner, Antje ^a   Kratzsch, Jürgen ^b   Kiess, Wieland ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipocytokines; Adiponectin; Adipose tissue; Leptin; Obesity; Resistin; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIDIABETIC AGENT; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RESISTIN; UNCLASSIFIED DRUG; VISFATIN;

ADIPOCYTE; ADIPOSE TISSUE; ATHEROSCLEROSIS; BODY FAT; CANCER; CARDIOVASCULAR DISEASE; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PREVALENCE; PROTEIN FUNCTION; REVIEW; STRESS;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; LEPTIN; MICE; RESISTIN;

EID: 29244476240     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2005.07.008     Document Type: Review

References (176)

1. Y. Zhang R. Proenca M. Maffei et al. Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425-432
2. E.E. Kershaw & J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548-2556
3. D.M. Muoio & D.G. Lynis Peripheral metabolic actions of leptin Best Pract Res Clin Endocrinol Metab 16 2002 653-666
4. G.H. Lee R. Proenca J.M. Montez et al. Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632-635
5. V.A. Barr Lane K & Taylor SI Subcellular localization and internalization of the four human leptin receptor isoforms. J Biol Chem 274 1999 21416-21424
6. N. Ghilardi S. Ziegler A. Wiestner S.T.A.T. Defective et al. signaling by the leptin receptor in diabetic mice Proc Natl Acad Sci USA 93 1996 6231-6235
7. G. Fruhbeck A heliocentric view of leptin Proc Nutr Soc 60 2001 301-318
8. C. Bjorbaek S. Uotani B. da Silva et al. Divergent signaling capacities of the long and short isoforms of the leptin receptor J Biol Chem 272 1997 32686-32695
9. A. Lammert W. Kiess A. Böttner et al. Soluble leptin receptor represents the main leptin binding activity in human blood Biochem Biophys Res Commun 283 2001 982-988
10. R. Devos Y. Guisez et al. Van der HJ.Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding J Biol Chem 272 1997 18304-18310
11. O. Gavrilova V. Barr B. Marcus-Samuels et al. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor J Biol Chem 272 1997 30546-30551
12. H. Ge L. Huang T. Pourbahrami et al. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo J Biol Chem 277 2002 45898-45903
13. M. Maamra M. Bidlingmaier M.C. Postel-Vinay et al. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors Endocrinology 142 2001 4389-4393
14. C. Liu X.J. Liu G. Barry et al. Expression and characterization of a putative high affinity human soluble leptin receptor Endocrinology 138 1997 3548-3554
15. L. Huang Wang Z & Li C Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 276 2001 6343-6349
16. M.K. Sinha I. Opentanova J.P. Ohannesian et al. Evidence of free and bound leptin in human circulation Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98 1996 1277-1282
17. J. Kratzsch A. Lammert A. Böttner et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence J Clin Endocrinol Metab 87 2002 4587-4594
18. G. Yang H. Ge A. Boucher et al. Modulation of direct leptin signaling by soluble leptin receptor Mol Endocrinol 18 2004 1354-1362
19. O. Zastrow B. Seidel W. Kiess et al. The soluble leptin receptor is crucial for leptin action: Evidence from clinical and experimental data Int J Obes Relat Metab Disord 27 2003 1472-1478
20. Dal Farra C, Zsurger N, Vincent JP et al. Binding of a pure 125I-monoiodoleptin analog to mouse tissues: A developmental study. Peptides 2000; 21: 577-587.
21. Bjorbaek C & Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59: 305-331.
22. S. Margetic C. Gazzola G.G. Pegg et al. Leptin: A review of its peripheral actions and interactions Int J Obes Relat Metab Disord 26 2002 1407-1433
23. S.B. Heymsfield A.S. Greenberg K. Fujioka et al. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial JAMA 282 1999 1568-1575
24. R.C. Frederich B. Lollmann A. Hamann et al. Expression of ob mRNA and its encoded protein in rodents Impact of nutrition and obesity. J Clin Invest 96 1995 1658-1663
25. R.V. Considine M.K. Sinha M.L. Heiman et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292-295
26. P.J. Havel S. Kasim-Karakas G.R. Dubuc et al. Gender differences in plasma leptin concentrations Nat Med 2 1996 949-950
27. R. Heptulla A. Smitten B. Teague et al. Temporal patterns of circulating leptin levels in lean and obese adolescents: Relationships to insulin, growth hormone, and free fatty acids rhythmicity J Clin Endocrinol Metab 86 2001 90-96
28. M.L. Wong J. Licinio B.O. Yildiz et al. Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: Dissociation of concentrations in central and peripheral compartments J Clin Endocrinol Metab 89 2004 258-265
29. R.V. Considine & J.F. Caro Leptin and the regulation of body weight Int J Biochem Cell Biol 29 1997 1255-1272
30. I.S. Farooqi G. Matarese G.M. Lord et al. Beneficial effects of leptin on obesity T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110 2002 1093-1103
31. Williamson DA, Ravussin E, Wong ML et al. Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite 2005.
32. O. Mammes D. Betoulle R. Aubert et al. Novel polymorphisms in the 5′ region of the LEP gene: Association with leptin levels and response to low-calorie diet in human obesity Diabetes 47 1998 487-489
33. W.D. Li D.R. Reed J.H. Lee et al. Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women Ann Hum Genet 63 1999 227-234
34. K. Clement C. Vaisse N. Lahlou et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 1998 398-401
35. El Haschimi K, Pierroz DD, Hileman SM et al. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000; 105: 1827-1832.
36. W.A. Banks The many lives of leptin Peptides 25 2004 331-338
37. C. Bjorbaek J.K. Elmquist J.D. Frantz et al. Identification of SOCS-3 as a potential mediator of central leptin resistance Mol Cell 1 1998 619-625
38. C. Bjorbaek et al. El Haschimi K Frantz JD.The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274 1999 30059-30065
39. A. Cheng N. Uetani P.D. Simoncic et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B Dev Cell 2 2002 497-503
40. J.M. Zabolotny K.K. Bence-Hanulec A. Stricker-Krongrad et al. PTP1B regulates leptin signal transduction in vivo Dev Cell 2 2002 489-495
41. M. Elchebly P. Payette E. Michaliszyn et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 283 1999 1544-1548
42. Munzberg H & Myers MG, Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005; 8: 566-570.
43. A. Singhal I.S. Farooqi T.J. Cole et al. Influence of leptin on arterial distensibility: A novel link between obesity and cardiovascular disease? Circulation 106 2002 1919-1924
44. M. Ciccone R. Vettor N. Pannacciulli et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery Int J Obes Relat Metab Disord 25 2001 805-810
45. R. Wolk P. Berger R.J. Lennon et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis J Am Coll Cardiol 44 2004 1819-1824
46. M.P. Reilly N. Iqbal M. Schutta et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872-3878
47. E.E. Calle C. Rodriguez K. Walker-Thurmond et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625-1638
48. P. Somasundar K.A. Frankenberry H. Skinner et al. Prostate cancer cell proliferation is influenced by leptin J Surg Res 118 2004 71-82
49. D.P. Rose Komninou D & Stephenson GD Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5 2004 153-165
50. P. Somasundar D.W. McFadden S.M. Hileman et al. Leptin is a growth factor in cancer J Surg Res 116 2004 337-349
51. P. Ducy M. Amling S. Takeda et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass Cell 100 2000 197-207
52. S. Takeda F. Elefteriou R. Levasseur et al. Leptin regulates bone formation via the sympathetic nervous system Cell 111 2002 305-317
53. S. Takeda Central control of bone remodeling Biochem Biophys Res Commun 328 2005 697-699
54. J.A. Pasco M.J. Henry K.M. Sanders et al. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study J Bone Miner Res 19 2004 19-24
55. R.G. Schlienger M.E. Kraenzlin S.S. Jick et al. Use of beta-blockers and risk of fractures JAMA 292 2004 1326-1332
56. A.R. Shuldiner Yang R & Gong DW Resistin, obesity and insulin resistance - the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345 2001 1345-1346
57. C.M. Steppan S.T. Bailey S. Bhat et al. The hormone resistin links obesity to diabetes Nature 409 2001 307-312
58. K.H. Kim K. Lee Y.S. Moon et al. cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation J Biol Chem 276 2001 11252-11256
59. I.N. Holcomb R.C. Kabakoff B. Chan et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO J 19 2000 4046-4055
60. C.M. Steppan E.J. Brown C.M. Wright et al. family of tissue-specific resistin-like molecules Proc Natl Acad Sci USA 98 2001 502-506
61. C.M. Steppan & M.A. Lazar The current biology of resistin J Intern Med 255 2004 439-447
62. T. Nohira K. Nagao K. Kameyama et al. Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue Eur J Endocrinol 151 2004 151-154
63. P. Raghu S. Ghosh K. Soundarya et al. Dimerization of human recombinant resistin involves covalent and noncovalent interactions Biochem Biophys Res Commun 313 2004 642-646
64. B. Aruna S. Ghosh A.K. Singh et al. Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages Biochemistry 42 2003 10554-10559
65. P.G. McTernan C.L. McTernan R. Chetty et al. Increased resistin gene and protein expression in human abdominal adipose tissue J Clin Endocrinol Metab 87 2002 2407
66. J.N. Fain P.S. Cheema S.W. Bahouth et al. Resistin release by human adipose tissue explants in primary culture Biochem Biophys Res Commun 300 2003 674-678
67. L. Patel A.C. Buckels I.J. Kinghorn et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem Biophys Res Commun 300 2003 472-476
68. S. Yura N. Sagawa H. Itoh et al. Resistin is expressed in the human placenta J Clin Endocrinol Metab 88 2003 1394-1397
69. A.H. Minn N.B. Patterson S. Pack et al. Resistin is expressed in pancreatic islets Biochem Biophys Res Commun 310 2003 641-645
70. J.M. Way C.Z. Gorgun Q. Tong et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists J Biol Chem 276 2001 25651-25653
71. C.C. Juan L.C. Au V.S. Fang et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids Biochem Biophys Res Commun 289 2001 1328-1333
72. M.W. Rajala Y. Qi H.R. Patel et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting Diabetes 53 2004 1671-1679
73. Rea R & Donnelly R. Resistin: An adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 2004; 6: 163-170.
74. Gerber M, Böttner A, Seidel B, et al. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005; 90: 4503-4509.
75. A. Pfutzner M. Langenfeld T. Kunt et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance Clin Lab 49 2003 571-576
76. B.S. Youn K.Y. Yu H.J. Park et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus J Clin Endocrinol Metab 89 2004 150-156
77. A. Fujinami H. Obayashi K. Ohta et al. Enzyme-linked immunosorbent assay for circulating human resistin: Resistin concentrations in normal subjects and patients with type 2 diabetes Clin Chim Acta 339 2004 57-63
78. K.N. Conneely K. Silander L.J. Scott et al. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects Diabetologia 47 2004 1782-1788
79. H. Osawa K. Yamada H. Onuma G.G. et al. The genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3 Am J Hum Genet 75 2004 678-686
80. Chung SS, Choi HH, Kim KW et al. Regulation of human resistin gene expression in cell systems: An important role of stimulatory protein 1 interaction with a common promoter polymorphic site. Diabetologia 2005.
81. L. Bouchard S.J. Weisnagel J.C. Engert et al. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study J Endocrinol Invest 27 2004 1003-1009
82. J.B. Seo M.J. Noh E.J. Yoo et al. Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha Mol Endocrinol 17 2003 1522-1533
83. Fasshauer M & Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46: 1594-1603.
84. Y.H. Chen P.F. Hung & Y.H. Kao IGF-I downregulates resistin gene expression and protein secretion Am J Physiol Endocrinol Metab 288 2005 E1019-E1027
85. H.S. Jung B.S. Youn Y.M. Cho et al. The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus Metabolism 54 2005 314-320
86. M.W. Rajala Y. Lin M. Ranalletta et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue Mol Endocrinol 16 2002 1920-1930
87. Kochan Z & Karbowska J. Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol Cell Endocrinol 2004; 218: 57-64.
88. E. Adeghate An update on the biology and physiology of resistin Cell Mol Life Sci 61 2004 2485-2496
89. F. Felipe M.L. Bonet J. Ribot et al. Modulation of resistin expression by retinoic acid and vitamin A status Diabetes 53 2004 882-889
90. B. Moon J.J. Kwan N. Duddy et al. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation Am J Physiol Endocrinol Metab 285 2003 E106-E115
91. M.W. Rajala S. Obici P.E. Scherer et al. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production J Clin Invest 111 2003 225-230
92. C.M. Steppan J. Wang E.L. Whiteman et al. Activation of SOCS-3 by resistin Mol Cell Biol 25 2005 1569-1575
93. Kim KH, Zhao L, Moon Y, et al. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 2004.
94. T. Ort A.A. Arjona J.R. MacDougall et al. Recombinant human FIZZ3/ resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice Endocrinology 146 2005 2200-2209
95. M. Wilkinson D. Wilkinson G. Wiesner et al. Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: Co-localization with alpha-melanostimulating hormone Neuroendocrinology 81 2005 19-30
96. L. Brunetti G. Orlando L. Recinella et al. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus Eur J Pharmacol 493 2004 41-44
97. Böttner A & Bornstein SR. Lessons learned from gene targeting and transgenesis for adrenal physiology and disease. Rev Endocr Metab Disord 2001; 2: 275-287.
98. R.R. Banerjee S.M. Rangwala J.S. Shapiro et al. Regulation of fasted blood glucose by resistin Science 303 2004 1195-1198
99. Y. Kitagawa H. Bujo K. Takahashi et al. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin Diabetologia 47 2004 1847-1853
100. N. Sato K. Kobayashi T. Inoguchi et al. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice Endocrinology 146 2005 273-279
101. H. Satoh M.T. Nguyen P.D. Miles et al. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats J Clin Invest 114 2004 224-231
102. G.K. Shetty P.A. Economides E.S. Horton et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450-2457
103. M.P. Reilly M. Lehrke M.L. Wolfe et al. Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932-939
104. M. Bokarewa I. Nagaev L. Dahlberg et al. Resistin, an adipokine with potent proinflammatory properties J Immunol 174 2005 5789-5795
105. P. Calabro I. Samudio J.T. Willerson et al. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways Circulation 110 2004 3335-3340
106. P. Kougias H. Chai P.H. Lin et al. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries J Vasc Surg 41 2005 691-698
107. S. Verma S.H. Li C.H. Wang et al. Resistin promotes endothelial cell activation: Further evidence of adipokine-endothelial interaction Circulation 108 2003 736-740
108. Y. Nakano T. Tobe N.H. Choi-Miura et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma J Biochem (Tokyo) 120 1996 803-812
109. E. Hu Liang P & Spiegelman BM AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 1996 10697-10703
110. K. Maeda K. Okubo I. Shimomura et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286-289
111. P.E. Scherer S. Williams M. Fogliano et al. A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746-26749
112. U.B. Pajvani et al. Du X Combs TP.Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278 2003 9073-9085
113. T.S. Tsao H.E. Murrey C. Hug et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30) J Biol Chem 277 2002 29359-29362
114. J. Fruebis T.S. Tsao S. Javorschi et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci USA 98 2001 2005-2010
115. M.E. Trujillo & P.E. Scherer Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome J Intern Med 257 2005 167-175
116. Fisher FF, Trujillo ME, Hanif W, et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 2005.
117. Böttner A, Kratzsch J, Seidel B, et al. Adiponectin expression is dependent on differentiation of adipocytes. In press.
118. Y. Matsuzawa T. Funahashi S. Kihara et al. Adiponectin and metabolic syndrome Arterioscler Thromb Vasc Biol 24 2004 29-33
119. A. Böttner J. Kratzsch G. Müller et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels J Clin Endocrinol Metab 89 2004 4053-4061
120. Y. Yamamoto H. Hirose I. Saito et al. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: Two-year follow-up study in Japanese population J Clin Endocrinol Metab 89 2004 87-90
121. J. Spranger A. Kroke M. Mohlig et al. Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226-228
122. M. Stumvoll O. Tschritter A. Fritsche et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes Diabetes 51 2002 37-41
123. F. Vasseur F. Lepretre C. Lacquemant et al. The genetics of adiponectin Curr Diab Rep 3 2003 151-158
124. Zacharova J, Chiasson JL & Laakso M. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. Diabetes 2005; 54: 893-899.
125. D.M. Maahs L.G. Ogden G.L. Kinney et al. Low plasma adiponectin levels predict progression of coronary artery calcification Circulation 111 2005 747-753
126. Filippi E, Sentinelli F, Romeo S, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
127. E.S. Kang S.Y. Park H.J. Kim et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes Diabetes Care 28 2005 1139-1144
128. N. Kubota Y. Terauchi T. Yamauchi et al. Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem 277 2002 25863-25866
129. N. Maeda I. Shimomura K. Kishida et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 2002 731-737
130. T. Yamauchi J. Kamon H. Waki et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 278 2003 2461-2468
131. A.H. Berg & P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ Res 96 2005 939-949
132. G. Fantuzzi Adipose tissue, adipokines, and inflammation J Allergy Clin Immunol 115 2005 911-919
133. B.J. Goldstein & R. Scalia Adiponectin: A novel adipokine linking adipocytes and vascular function J Clin Endocrinol Metab 89 2004 2563-2568
134. Hug C & Lodish HF. The role of the adipocyte hormone adiponectin in cardiovascular disease. Curr Opin Pharmacol 2005; 5: 129-134.
135. Y. Matsuzawa Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease Atheroscler Suppl 6 2005 7-14
136. A.H. Berg T.P. Combs et al. Du X. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 2001 947-953
137. Fu Y, Luo N, Klein RL et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation: Potential role in autoregulation of adipocyte metabolism and adipose mass. J Lipid Res 2005.
138. Y. Wang K.S. Lam J.Y. Xu et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner J Biol Chem 280 2005 18341-18347
139. M. Ishikawa J. Kitayama S. Kazama et al. Plasma adiponectin and gastric cancer Clin Cancer Res 11 2005 466-472
140. Y. Miyoshi T. Funahashi S. Kihara et al. Association of serum adiponectin levels with breast cancer risk Clin Cancer Res 9 2003 5699-5704
141. E. Brakenhielm N. Veitonmaki R. Cao et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis Proc Natl Acad Sci USA 101 2004 2476-2481
142. T. Yamauchi J. Kamon Y. Ito et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762-769
143. M. Gil-Campos R.R. Canete & A. Gil Adiponectin, the missing link in insulin resistance and obesity Clin Nutr 23 2004 963-974
144. Kadowaki T & Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
145. Chen MB, McAinch AJ, Macaulay SL et al. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle from obese type 2 diabetics. J Clin Endocrinol Metab 2005.
146. A. Tsuchida T. Yamauchi Y. Ito et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity J Biol Chem 279 2004 30817-30822
147. K. Inukai Y. Nakashima M. Watanabe et al. Regulation of adiponectin receptor gene expression in diabetic mice Am J Physiol Endocrinol Metab 288 2005 E876-E882
148. H. Staiger S. Kaltenbach K. Staiger et al. Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism Diabetes 53 2004 2195-2201
149. A.E. Civitarese C.P. Jenkinson D. Richardson et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes Diabetologia 47 2004 816-820
150. H. Wang H. Zhang Y. Jia et al. Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance Diabetes 53 2004 2132-2136
151. C. Hug J. Wang et al. NST-c Ahmad cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin Proc Natl Acad Sci USA 101 2004 10308-10313
152. A.F. Soares M. Guichardant D. Cozzone et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes Free Radic Biol Med 38 2005 882-889
153. M. Iwaki M. Matsuda N. Maeda et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 2003 1655-1663
154. A.S. Lihn S.B. Pedersen & B. Richelsen Adiponectin: Action, regulation and association to insulin sensitivity Obes Rev 6 2005 13-21
155. A. Kita H. Yamasaki H. Kuwahara et al. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha Biochem Biophys Res Commun 331 2005 484-490
156. S.K. Park S.Y. Oh M.Y. Lee et al. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue Diabetes 53 2004 2757-2766
157. M. Degawa-Yamauchi K.A. Moss J.E. Bovenkerk et al. Regulation of adiponectin expression in human adipocytes: Effects of adiposity, glucocorticoids, and tumor necrosis factor {alpha} Obes Res 13 2005 662-669
158. L. Nilsson N. Binart Y. Bohlooly et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue Biochem Biophys Res Commun 331 2005 1120-1126
159. A. Xu K.W. Chan R.L. Hoo et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes J Biol Chem 280 2005 18073-18080
160. A. Fukuhara M. Matsuda M. Nishizawa et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426-430
161. C. Hug & H.F. Lodish Medicine. Visfatin: A new adipokine. Science 307 2005 366-367
162. J. Boucher B. Masri D. Daviaud et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764-1771
163. E.A. Ashley J. Powers M. Chen et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc Res 65 2005 73-82
164. A. Kasai N. Shintani M. Oda et al. Apelin is a novel angiogenic factor in retinal endothelial cells Biochem Biophys Res Commun 325 2004 395-400
165. N. De Mota et al. Reaux-Le Goazigo A El Messari S. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101 2004 10464-10469
166. N. Komazawa M. Matsuda G. Kondoh et al. Enhanced insulin sensitivity, energy expenditure and thermogenesis in adipose-specific Pten suppression in mice Nat Med 10 2004 1208-1215
167. S. Mandard F. Zandbergen N.S. Tan et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment J Biol Chem 279 2004 34411-34420
168. S. Baulande F. Lasnier M. Lucas et al. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage J Biol Chem 276 2001 33336-33344
169. Y.M. Liu M. Moldes J.P. Bastard et al. Adiponutrin: A new gene regulated by energy balance in human adipose tissue J Clin Endocrinol Metab 89 2004 2684-2689
170. D.A. Polson & M.P. Thompson Adiponutrin mRNA expression in white adipose tissue is rapidly induced by meal-feeding a high-sucrose diet Biochem Biophys Res Commun 301 2003 261-266
171. N.E. Wolins B.K. Quaynor J.R.S.3-1.2. Skinner et al. Adipophilin, and TIP47 package lipid in adipocytes J Biol Chem 280 2005 19146-19155
172. J.T. Tansey C. Sztalryd E.M. Hlavin et al. The central role of perilipin a in lipid metabolism and adipocyte lipolysis IUBMB Life 56 2004 379-385
173. K.T. Dalen K. Schoonjans S.M. Ulven et al. Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma Diabetes 53 2004 1243-1252
174. Y. Bao C. Bing L. Hunter et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes FEBS Lett 579 2005 41-47
175. J. Rehman R.V. Considine J.E. Bovenkerk et al. Obesity is associated with increased levels of circulating hepatocyte growth factor J Am Coll Cardiol 41 2003 1408-1413
176. N. Rahimi R. Saulnier T. Nakamura et al. Role of hepatocyte growth factor in breast cancer: A novel mitogenic factor secreted by adipocytes DNA Cell Biol 13 1994 1189-1197